Endothelial vasoactive mediators in preeclampsia†,‡
References (25)
- et al.
Factor VIII consumption in pre-eclampsia
Lancet
(1977) - et al.
Plasma fibronec-tin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage
Am J Obstet Gynecol
(1984) - et al.
Increased plasma levels of EDI+ cellular fibronectin precede the clinical signs of preeclampsia
Am J Obstet Gynecol
(1990) - et al.
Thromboxane A2 synthesis in pregnancy-induced hypertension
Lancet
(1990) Preeclampsia: an imbalance in placental prostacyclin and thromboxane production
Am J Obstet Gynecol
(1985)- et al.
Human a- and ß-calcitonin gene-related peptides are vasodilators in human chorionic plate vasculature
Am J Obstet Gynecol
(1989) - et al.
Determination of leukotrienes and Prostaglandines in [14C] arachidonic acid labelled human lung tissue by high-performance liquid chromatography and radioimmunoassay
J Chromatogr
(1984) - et al.
Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe preeclampsia
Eur J Obstet Gynecol Reprod Biol
(1991) - et al.
Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells
Am J Obstet Gynecol
(1988) - et al.
Preeclampsia: an endothelial cell disorder
Am J Obstet Gynecol
(1989)
Placental-type plasminogen activator inhibitor in preeclampsia
Am J Obstet Gynecol
Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels
Am J Obstet Gynecol
Cited by (106)
Placental Endocrine Function and Hormone Action
2015, Knobil and Neill's Physiology of Reproduction: Two-Volume SetCirculating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies
2006, American Journal of Obstetrics and GynecologyCitation Excerpt :Furthermore, our data indicated that both maternal and fetal plasma CGRP positively correlated with fetal birth weight, suggesting that in pregnancy, CGRP may be involved in the regulation of uteroplacental blood flow. However, few other reports indicated that maternal and fetal plasma CGRP levels in preeclampsia did not significantly differ from maternal and fetal CGRP levels of normal pregnancies,16 possibly due to a wide range of values observed in both groups. In another report,17 the data failed to demonstrate a difference in plasma CGRP levels between nonpregnant and pregnant women despite the well-known increase of CGRP in maternal plasma in pregnancy.18
Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia
2006, American Journal of Obstetrics and GynecologyCitation Excerpt :During pregnancy, accelerated endothelial dysfunction is a central feature of both preeclampsia and IUGR. Endothelial activators such as vascular cellular adhesion molecule-1 (VCAM), intercellular adhesion molecule-1 (ICAM), endothelin-1, cellular fibronectin, and E-selectin are elevated in the maternal serum and plasma of women with both conditions,29-36 although activator levels in preeclampsia exceed those observed in IUGR. Markers of endothelial dysfunction are evident months before the clinical recognition of preeclampsia.30
Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia
2005, International Journal of Gynecology and ObstetricsSoluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia
2023, Journal of Maternal-Fetal and Neonatal Medicine
- †
Supported by grants from Organon International.
- ‡
Presented at the Twelfth Annual Meeting of the Society of Perinatal Obstetricians, Orlando, Florida, February 3–8, 1992.
- a
From the Department of Obstetrics and Gynecology Chemistry, Free University Hospital.
- b
From the Department of Clinical Chemistry, Free University Hospital.